# Western New England Bancorp, Inc.: overview WNEB · Nasdaq · CIK 1157647 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/wneb.md) · [Financials](/companies/wneb/financials.md) · [Filings](/companies/wneb/filings.md) · [Insiders](/companies/wneb/insiders.md) Latest reported revenue: [$11.0k](/filings/0001387131-21-008219.md) for Q2 FY2021, three months to 2021-06-30, from the 10-Q filed Aug 6, 2021 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001387131-21-008219). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.09](/filings/0001999371-26-006029.md) | [0.16](/filings/0001999371-26-006029.md) | [0.11](/filings/0001999371-26-010347.md) | [0.23](/filings/0001999371-26-017418.md) | [0.16](/filings/0001999371-26-006029.md) | [0.26](/filings/0001999371-26-006029.md) | [0.24](/filings/0001999371-26-010347.md) | [0.18](/filings/0001999371-26-017418.md) | | Free cash flow | $k | not reported | [5,240 d](/filings/0001999371-26-006029.md) | [(1,116)](/filings/0001999371-26-010347.md) | [6,543 d](/filings/0001999371-26-017418.md) | [4,974 d](/filings/0001999371-25-017260.md) | [6,395 d](/filings/0001999371-26-006029.md) | [(388)](/filings/0001999371-26-010347.md) | [5,872 d](/filings/0001999371-26-017418.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.02](/filings/0001999371-24-003319.md) | [1.18](/filings/0001839882-25-014778.md) | [0.70](/filings/0001999371-26-006029.md) | [0.56](/filings/0001999371-26-006029.md) | [0.75](/filings/0001999371-26-006029.md) | | Free cash flow | $m | [25.3](/filings/0001999371-24-003319.md) | [35.6](/filings/0001839882-25-014778.md) | [11.9](/filings/0001999371-26-006029.md) | [11.0](/filings/0001999371-26-006029.md) | [17.1](/filings/0001999371-26-006029.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wneb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $26.3m | 1,836,760 | | Added +123,132 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $20.3m | 1,419,535 | | Added +8,781 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $13.6m | 947,562 | | Reduced −53,200 | | [STRATEGIC VALUE BANK PARTNERS LLC](/funds/1904067.md) | 2026-06-30 | $12.4m | 865,565 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.5m | 736,026 | | Reduced −119,172 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $10.5m | 731,557 | | Reduced −6,540 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $9.9m | 693,940 | | Reduced −6,628 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.3m | 438,035 | | Added +38,476 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $4.4m | 305,835 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.8m | 266,675 | | Reduced −3,988 | ## Recent filings [All 1,270 filings](/companies/wneb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 16:20 ET | [10-Q](/filings/0001999371-26-017418.md) | Quarterly report, period 2026-06-30 | 0001999371-26-017418 | | 2026-07-28 | 16:33 ET | [8-K](/filings/0001999371-26-016255.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001999371-26-016255 | | 2026-05-14 | 16:35 ET | [8-K](/filings/0001999371-26-010740.md) | 5.07 Shareholder vote results | 0001999371-26-010740 | | 2026-05-14 | 10:03 ET | [8-K](/filings/0001999371-26-010681.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001999371-26-010681 | | 2026-05-08 | 16:17 ET | [10-Q](/filings/0001999371-26-010347.md) | Quarterly report, period 2026-03-31 | 0001999371-26-010347 | | 2026-04-28 | 16:21 ET | [8-K](/filings/0001999371-26-009255.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001999371-26-009255 | | 2026-04-03 | 09:30 ET | [DEF 14A](/filings/0001999371-26-007628.md) | Proxy statement, period 2026-05-14 | 0001999371-26-007628 | | 2026-03-16 | 17:08 ET | [10-K/A](/filings/0001999371-26-006029.md) | Annual report, amended, period 2025-12-31 | 0001999371-26-006029 | | 2026-03-10 | 16:08 ET | [10-K](/filings/0001999371-26-005514.md) | Annual report, period 2025-12-31 | 0001999371-26-005514 | | 2026-02-27 | 17:02 ET | [8-K](/filings/0001999371-26-004635.md) | 5.02 Departure or appointment of officers or directors | 0001999371-26-004635 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001999371-26-005514.md), filed Mar 10, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1157647 - Tickers: WNEB - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MA - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:28 ET. No prices; not investment advice.